Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $16.22M in the quarter ending December 31, 2024, a decrease of -13.48%. This brings the company's revenue in the last twelve months to $77.23M, down -14.22% year-over-year. In the fiscal year ending June 30, 2024, Aytu BioPharma had annual revenue of $81.00M, down -24.58%.

• Revenue (ttm): $77.23M
• Revenue Growth: -14.22%
• P/S Ratio: 0.09
• Revenue / Employee: $757,176
• Employees: 102
• Market Cap: 7.65M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	81.00M	-26.40M	-24.58%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	20.31M	277.47%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.